You are here: Industry Insights > Cell Lines

News List

Genomic Vision Launches HexaCard, a New Service to CharacterizeCell Lines Used for Biomanufacturing and Cell & Gene Therapy PharmaSources
July 18, 2023
Genomic Vision Launches HexaCard, a New Service to CharacterizeCell Lines Used for Biomanufacturing and Cell & Gene Therapy.
ProBioGen, LAVA to Develop Cell Lines for Bispecific Candidate contractpharma
June 23, 2021
ProBioGen will conduct cell line development of a novel gamma-delta bsTCE using its CHO.RiGHT expression platform.
Dyadic to Develop Cell Lines for COVID-19 Vaccine Candidates contractpharma
June 11, 2020
Selected by the Frederick National Laboratory to engineer proprietary C1 cell lines.
Abcam acquires EdiGene’s Knock-out cell lines and Lysates Portfolio biospectrumasia
July 17, 2019
Using their proprietary high throughput cell editing platform, EdiGene developed the industry’s largest off-the shelf diploid library of over 2,800 single clonal knockout (KO) cell lines
Robotic method isolates high-producing cell lines for HIV vaccine production europeanpharmaceuticalreview
April 29, 2019
Technical advances in vaccine production should shorten the time to clinical trials, breaking the logjam of promising new candidate vaccines waiting to be tested…
Oxford Genetics signs major supply and licensing agreement for CRISPR engineered mammalian cell lines biospectrumasia
August 14, 2018
Company moves away from manual processing in favour of automated, scalable platforms.
Evotec and Celgene Expand IPSC Collaboration to Include Additional Cell Lines firstwordpharma
May 30, 2018
Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that the Company will receive a $ 6 m payment from Celgene following Celgene's decision to expand the collaboration to include additional cell lines.
Over 30,000 published articles have mistaken cell lines. What about yours? en-cphi.cn
October 30, 2017
The famous HeLa cells are world’s first immortal cell line and one of the most important and commonly used cell lines in medical research.
PCM-075 Demonstrates Synergy with HDAC Inhibitor in Non-Hodgkin Lymphoma Cell Lines americanpharmaceuticalreview
August 22, 2017
Trovagene announced compelling results of preclinical research of PCM-075 with a Histone deacetylase (HDAC) inhibitor in Non-Hodgkin Lymphoma (NHL) cell lines.
Cell lines and media for difficult to culture tumour types cphi-online
February 24, 2017
Aids R&D initiatives to advance precision medicine. AMSBIO has introduced a new range of cancer cell line models and culture media for the most difficult to culture tumour types where no models may exist.